期刊文献+

维持性血液透析患者残余尿量对钙磷代谢的影响 被引量:3

The effectrelationship between the metabolism of Calcium-phosphorus and the residual urine inof the Maintenance Hemodialysis Patients' Residual Urine Volume on Calcium-phosphorus Metabolism
下载PDF
导出
摘要 目的研究维持性血液透析(MHD)患者钙、磷代谢紊乱与残余尿量的关系,以便更好地保护残余尿量,控制钙、磷代谢紊乱。方法以血液透析中心MHD≥3个月患者作为研究对象。入选患者检测透析前全段甲状旁腺激素(i PTH)水平、血清钙磷水平。根据残余尿量(无尿组尿量≤100 m L/24 h和有尿组尿量﹥100 m L/24h)进行分组,对各组间血清钙磷与i PTH等进行比较。结果有尿组和无尿组i PTH比较差异有统计学意义(P<0.05),但血清钙磷差异无统计学意义(P>0.05)。结论维持性血液透析患者残余尿量对预防和减轻钙磷代谢紊乱、继发性甲状旁腺功能亢进有重要意义。 Objective To study the relationship between the calcium - phosphorus metabolic disorders of MHD patients withand the residual urine in the Maintenance Hemodialysis (MHD) patients volume, in order to better protect the residual urine volume and control the calcium - phosphorus metabolic disorders. Method It tookThe patients who had receivinged MHD for more than ≥3 months in the hemodialysis center of the Shizuishan 1st People's Hospital were collected and te as the research object. It testeds the iPTH levels of , iPTH , serum calcium and phosphorus level in serum of the patients before receiving dialysis. Then their classifies patients were classified into different groups in accordance with the residual urine volume (urinefree group: urine volume ≤ 100 mL/24 h;urine group: urine volume 〉 100 mL/24 h) and compareds the groups in terms of their serum the calcium,phosphorus and iPTH in the groups. Results The iPTH difference of iPTH between urine - free group and urine group hasd statistics significance ( P 〈 0.05 ) while the differences between them in terms of the serum calcium and phosphorus were not do not have statistics significance. Conclusion Maintaining the residual urine volume of the maintenance hemodialysis patients has great significances on preventing and alleviating the calci- umphosphorous disorders and the secondary hyperparathyroidism.
出处 《宁夏医学杂志》 CAS 2017年第2期130-131,共2页 Ningxia Medical Journal
关键词 维持性血液透析 甲状旁腺激素 残余尿量 Maintenance hemodialysis Parathyroid hormone Residual urine volume
  • 相关文献

参考文献2

二级参考文献19

  • 1Bargman J, Thorpe K, Churchill D. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol, 2001, 12: 2158-2162. 被引量:1
  • 2Shemin D, Bostom A, Laliberty P, et al. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis, 2001, 38: 85-90. 被引量:1
  • 3Van Biesen W, Vanholder R, Veys N, et al. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol, 2000, 11: 116-125. 被引量:1
  • 4Li P, Chow K-M, Wong T, et al. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. Ann Intern Med, 2003, 139: 105-112. 被引量:1
  • 5Suzuki H, Kanno Y, Sugahara S, et al. Effects of an angiotensin Ⅱ receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis, 2004, 43: 1056-1064. 被引量:1
  • 6Jassal S, Lok C, Walele A, et al. Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: results of a decision analysis. Am J Kidney Dis, 2002, 40: 178-183. 被引量:1
  • 7Maiorca R, Brunori G, Zubani R, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant, 1995, 10: 2295-2305. 被引量:1
  • 8Jansen M, Hart A, Korevaar J, et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int, 2002, 62: 1046-1053. 被引量:1
  • 9Alpem R J, Sakhaee K. The clinical spectrum of chronic metabolic acidosis : Homeostatic mechanisms produce significant morbidity [J]. Am J Kidney Dis, 1997,29(2): 291- 302. 被引量:1
  • 10Hory B, Drueke T B. The parathyroid-bone axis in uremia: New insights into old questions [J]. Curt Opin Nephrol Hypertens, 1997,6(1): 40-48. 被引量:1

共引文献50

同被引文献22

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部